Russell Investments Group Ltd. Sells 83,899 Shares of Celsius Holdings Inc. $CELH

Key Points

• Russell Investments Group Ltd. drastically reduced its stake in Celsius Holdings Inc. by 96.1%, selling 83,899 shares and leaving it with only 3,387 shares valued at approximately $121,000.
• Major shareholder William H. Milmoe sold 300,000 shares of Celsius at an average price of $47.27, resulting in a total transaction of over $14 million.
• Celsius reported strong quarterly earnings, with an EPS of $0.47, surpassing analysts' expectations, and a revenue of $739.30 million, marking an increase of 83.9% year-over-year.

Russell Investments Group Ltd. lowered its holdings in shares of Celsius Holdings Inc. (NASDAQ:CELH - Free Report) by 96.1% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 3,387 shares of the company's stock after selling 83,899 shares during the period. Russell Investments Group Ltd.'s holdings in Celsius were worth $121,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Triumph Capital Management raised its holdings in Celsius by 41.5% in the fourth quarter. Triumph Capital Management now owns 40,420 shares of the company's stock worth $1,065,000 after buying an additional 11,863 shares during the last quarter. Fifth Third Bancorp boosted its stake in shares of Celsius by 62.9% in the first quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock worth $61,000 after acquiring an additional 666 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Celsius by 4,164.4% during the first quarter. GAMMA Investing LLC now owns 73,092 shares of the company's stock worth $2,604,000 after acquiring an additional 71,378 shares during the period. Oppenheimer & Co. Inc. grew its position in shares of Celsius by 14.0% during the first quarter. Oppenheimer & Co. Inc. now owns 9,760 shares of the company's stock worth $348,000 after acquiring an additional 1,199 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. grew its stake in Celsius by 21.4% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 45,517 shares of the company's stock valued at $1,621,000 after acquiring an additional 8,009 shares during the last quarter. Hedge funds and other institutional investors own 60.95% of the company's stock.

Celsius Stock Down 6.1%

Shares of CELH traded down $3.56 on Monday, reaching $54.81. The company's stock had a trading volume of 6,330,246 shares, compared to its average volume of 8,059,469. The company has a current ratio of 2.11, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $14.14 billion, a PE ratio of 147.76, a PEG ratio of 1.32 and a beta of 1.33. Celsius Holdings Inc. has a twelve month low of $21.10 and a twelve month high of $63.50. The firm has a fifty day moving average of $51.32 and a 200-day moving average of $41.24.

Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The firm had revenue of $739.30 million for the quarter, compared to analysts' expectations of $632.13 million. During the same quarter in the previous year, the company earned $0.28 earnings per share. The company's revenue for the quarter was up 83.9% compared to the same quarter last year. Equities analysts predict that Celsius Holdings Inc. will post 0.89 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on CELH shares. Needham & Company LLC increased their target price on shares of Celsius from $60.00 to $70.00 and gave the company a "buy" rating in a research note on Friday. Bank of America upped their price target on shares of Celsius from $35.00 to $40.00 and gave the stock an "underperform" rating in a report on Friday, August 8th. Wall Street Zen cut shares of Celsius from a "buy" rating to a "hold" rating in a research note on Sunday, August 17th. Cowen reissued a "buy" rating on shares of Celsius in a research note on Tuesday, September 2nd. Finally, Mizuho lifted their target price on shares of Celsius from $85.00 to $90.00 and gave the stock an "outperform" rating in a research note on Tuesday, September 2nd. Seventeen analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $61.42.

Insider Transactions at Celsius

In other Celsius news, major shareholder Deborah Desantis sold 100,000 shares of Celsius stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the completion of the sale, the insider directly owned 17,717,770 shares in the company, valued at $841,594,075. This trade represents a 0.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO John Fieldly sold 143,167 shares of the stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $51.18, for a total transaction of $7,327,287.06. Following the sale, the chief executive officer owned 895,410 shares of the company's stock, valued at approximately $45,827,083.80. This represents a 13.78% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,123,641 shares of company stock valued at $52,998,580. Company insiders own 2.20% of the company's stock.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.